The aim of this study was to induce hepcidin overexpression to observe the protective effects of hepcidin in postmenopausal osteoporosis, and further provide new targets for the clinical treatment of postmenopausal osteoporosis. This evidence concerns the gene HAMP and postmenopausal osteoporosis.